Delivery Order SPE2DB25D3017-SPE2DB25FVKFB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,593.77 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count package) on July 28, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Calquence is a prescription oncology medication used in the treatment of certain blood cancers,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,593.77 for 60 tablets of Calquence 100 mg on August 14, 2025, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Calquence is a prescription medication used in oncology treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $11,187.56 to AmerisourceBergen Drug Corp for Calquence 100 mg tablets (60-count units) with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded on August 13, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $5,593.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Calquence 100 mg tablets (60-count units). The contract, which is expected to be completed by August 11, 2025, is non-set-aside and represents a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) under a firm fixed-price contract valued at $5,593.77. This non-competitive delivery order, issued on July 29, 2025, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Calquence 100 mg tablets (60-count package) valued at $11,187.56. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 2, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement under the company's existing indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,187.56 for Calquence 100 mg tablets (60-count units) on August 11, 2025, with completion targeted for September 2, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a $22,375.12 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Calquence 100 mg, with performance to be completed by September 9, 2025. This contract award employs firm fixed price terms and carries no set-aside designation, indicating the award was made through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Calquence 100 mg tablets (60 count) with a ceiling value of $5,593.77. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order valued at $11,187.56 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement...
- SPE2DB25D3017Indefinite Delivery Contract
- SPE2DB25D3017-SPE2DB25FVKFBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $11,187.56 to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (quantity 60) on August 13, 2025, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Calquence is a pharmaceutical product used in the treatment of hematologic malignancies, reflecting the Defense Logistics Agency's ongoing procurement of specialized medications to support military and veteran healthcare systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply an extensive range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.2k | 8/13/25 |